- Report
- March 2021
- 99 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,235GBP
- Report
- March 2021
- 345 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,235GBP
- Report
- September 2019
- 399 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,235GBP
- Report
- December 2018
- 235 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,235GBP
- Report
- May 2020
- 261 Pages
United Kingdom
€3260EUR$3,540USD£2,685GBP
- Report
- January 2023
- 150 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- May 2023
- 150 Pages
Global
From €4624EUR$4,850USD£3,941GBP
- Report
- October 2023
- 90 Pages
Japan
From €3337EUR$3,500USD£2,844GBP
- Report
- December 2021
- 120 Pages
Global
From €2383EUR$2,500USD£2,031GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2145EUR$2,250USD£1,828GBP
- Report
- January 2022
- 60 Pages
Global
From €3766EUR$3,950USD£3,210GBP
- Report
- December 2022
- 68 Pages
Global
- Report
- September 2022
- 67 Pages
Global
- Report
- September 2022
- 62 Pages
Global
From €4719EUR$4,950USD£4,022GBP
- Report
- November 2021
- 73 Pages
Global
From €4719EUR$4,950USD£4,022GBP
- Report
- May 2021
- 33 Pages
Global
- Report
- June 2020
- 65 Pages
Global
- Report
- January 2022
- 122 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- August 2020
- 92 Pages
Asia Pacific
From €2002EUR$2,100USD£1,706GBP
€2860EUR$3,000USD£2,438GBP
- Report
- August 2020
- 93 Pages
Europe
From €2002EUR$2,100USD£1,706GBP
€2860EUR$3,000USD£2,438GBP
The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more